Clinical Trial Update: A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial evaluates the immune response and safety of an investigational combined measles, mumps, rubella and varicella vaccine administered i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• MMRV vaccine (investigational, combined measles-mumps-rubella-varicella vaccine) (measles-mumps-rubella-varicella vaccine, investigational (combined))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Measles | Phase 3 | Status: NOT_YET_RECRUITING